MedGenome Labs Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
MedGenome Labs Limited - overview
Established
2013
Location
Bangalore, Karnataka, India
Primary Industry
Biotechnology
About
MedGenome Labs Limited is a biotechnology company specializing in genomics and precision medicine, offering a range of advanced genomic sequencing and bioinformatics solutions to enhance health outcomes globally. MedGenome Labs Limited, founded in 2013 and headquartered in Bangalore, India, focuses on genomics to improve precision medicine. The company has completed a total of 12 funding deals, with the most recent funding round being Series E. Vedam Ramprasad is the CEO of the company.
MedGenome Labs Limited specializes in sequencing services that include whole genome sequencing (WGS), whole exome sequencing (WES), RNA sequencing, single-cell sequencing, and immune repertoire sequencing. The company utilizes advanced technologies and AI-driven bioinformatics to convert complex biological data into actionable insights, thereby supporting drug development and diagnostics. Their clientele comprises leading academic institutions, biopharmaceutical companies, clinical diagnostic laboratories, and contract research organizations across North America, Europe, Asia, and Latin America, focusing on therapeutic areas such as oncology, immunology, rare diseases, and neurology. In the most recent fiscal year 2023, MedGenome Labs Limited recorded a revenue of USD 30.
44 mn, with an EBITDA of USD -1. 58 mn. MedGenome Labs Limited plans to utilize the USD 50 mn raised in Series D funding to expand its market presence and enhance product development in genetic testing, contributing to the global genomic dataset. In July 2025, MedGenome Labs Limited raised INR 4 billion in series E funding led by Maj Invest and Novo Holdings, with participation from Sofina.
MedGenome Labs Limited will use the July 2025 funding to expand access to its genomics and diagnostic services in India and other emerging markets.
Current Investors
Sequoia, Sofina, Zodius Capital
Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Molecular Science, Genetics & Gene Therapy, Diagnostic, Medical & Imaging Laboratories, Medical Software
Website
www.medgenome.com/
Verticals
HealthTech, Mobile Apps
Company Stage
Series E
Total Amount Raised
Subscriber access only
MedGenome Labs Limited - timeline of key events
MedGenome Labs Limited - financials
| Fiscal Year Ended | Mar 31, 2014 | Mar 31, 2015 | Mar 31, 2016 | Mar 31, 2017 | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 24,777,570 | 225,384,572 | 592,479,302 | 958,081,238 | 1,007,555,257 | 1,106,322,813 | 1,087,069,016 | 1,642,678,995 | - | - | - |
| % Revenue Growth (YoY) | - | 809.6% | 162.9% | 61.7% | 5.2% | 9.8% | (1.7%) | 51.1% | - | - | - |
| EBITDA (USD) | (4,406,814) | 10,590,779 | 54,911,753 | 132,231,486 | (533,126) | (117,370,259) | (284,070,442) | 296,777,062 | - | - | - |
| Operating Income (USD) | (4,456,025) | 4,324,673 | 6,700,947 | 15,760,498 | (165,587,351) | (298,560,026) | (474,417,258) | 134,960,236 | - | - | - |
| Operating Margin | (18.0%) | 1.9% | 1.1% | 1.6% | (16.4%) | (27.0%) | (43.6%) | 8.2% | - | - | - |
| % EBITDA Margin | (17.8%) | 4.7% | 9.3% | 13.8% | (0.1%) | (10.6%) | (26.1%) | 18.1% | - | - | - |
| NET Income (USD) | (4,528,996) | 2,265,978 | 3,458,089 | 15,473,463 | (174,803,511) | (304,717,670) | (484,764,205) | 104,958,995 | - | - | - |
| % Net Margin | (18.3%) | 1.0% | 0.6% | 1.6% | (17.3%) | (27.5%) | (44.6%) | 6.4% | - | - | - |
MedGenome Labs Limited - employee data
MedGenome Labs Limited - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Chairman Of The Board | BM | ||||||
| Chairman Of The Board | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.